---
title: "Tremfya (guselkumab), all indications: Access and coverage questions"
description: "Access and coverage questions on Tremfya (guselkumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Cost and coverage, Prior authorization, Access support, and Patient support. Questions: How much does Tremfya cost with the copay savings program? Can Medicare patients use the Tremfya savings program? Does the Tremfya savings program cover lab test costs? Does the Tremfya savings program work with accumulators, maximizers, or SaveOnSP? 7 further questions follow. 11 questions quoted from 9 sources."
canonical: "https://www.evicenter.com/medical-information/tremfya/access-and-coverage"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Tremfya (guselkumab), all indications: Access and coverage questions

Manufacturer: Janssen Biotech, Inc.  
Prescribing information: [Tremfya](https://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/TREMFYA-pi.pdf)  
Indication pages: [Plaque psoriasis](https://www.evicenter.com/medical-information/tremfya--plaque-psoriasis)

## Cost and coverage

<a id="tremfya-cost-savings-program"></a>

### How much does Tremfya cost with the copay savings program?

> “Eligible commercial patients* pay
> $0
> per dose”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#for-comercial-insurance:~:text=Eligible%20commercial%20patients%2A%20pay,per%20dose)

On the page, select: Commercial or private insurance

> “*Patients may be eligible for the TREMFYA withMe Savings Program if they are age 18 or older, use commercial or private health insurance for their prescribed TREMFYA<sup>®</sup>, and must pay an out-of-pocket cost for their treatment.”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#for-comercial-insurance:~:text=%2APatients%20may%20be%20eligible%20for,out%2Dof%2Dpocket%20cost%20for%20their%20treatment.)

On the page, select: Commercial or private insurance

> “Maximum program benefit per calendar year shall apply. Offer subject to change or end without notice. See program requirements at TREMFYAwithMeSavings.com”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#for-comercial-insurance:~:text=Maximum%20program%20benefit%20per%20calendar,See%20program%20requirements%20at%20TREMFYAwithMeSavings.com)

On the page, select: Commercial or private insurance

> “Medicine Cost Support can help eligible patients pay $0 per dose. Maximum program benefit per calendar year shall apply. Terms 
> expire at the end of each calendar year. Offer subject to change or end without notice. Restrictions, including monthly maximums, 
> may apply.”

Source: [TREMFYA: TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf, page 2, captured 2026-11-13](https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf#page=2)

> “You may be eligible for the Medicine Cost Support through TREMFYA withMe Savings Program if you are prescribed TREMFYA<sup>®</sup>  
> for an FDA-approved indication, use commercial or private health insurance for your prescribed TREMFYA<sup>®</sup>, and must pay an  
> out-of-pocket cost for your medicine. Participate without sharing your income information.”

Source: [TREMFYA: TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf, page 2, captured 2026-11-13](https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf#page=2)

Note: The HCP page states an age requirement of 18 or older; the program requirements document lists eligibility without an age criterion and adds that restrictions, including monthly maximums, may apply.

<a id="tremfya-savings-medicare"></a>

### Can Medicare patients use the Tremfya savings program?

> “This program is not for people who use any state or federal government-funded healthcare program. Examples of 
> these programs are Medicare, Medicaid, TRICARE, Department of Defense, and Veterans Administration.”

Source: [TREMFYA: TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf, page 3, captured 2026-11-13](https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf#page=3)

> “For patients with government coverage, TREMFYA withMe can provide information about resources that may help them with their out-of-pocket costs.”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#for-goverment-insurance:~:text=For%20patients%20with%20government%20coverage%2C,them%20with%20their%20out%2Dof%2Dpocket%20costs.)

On the page, select: Government coverage

<a id="tremfya-savings-lab-tests"></a>

### Does the Tremfya savings program cover lab test costs?

> “TREMFYA withMe Savings Program
> for eligible patients using commercial insurance”

Source: [TREMFYA: TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf, page 1, captured 2026-11-13](https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf#page=1)

> “Treatment Administration Cost Support can help eligible patients save on out-of-pocket costs for: 
> • Required laboratory tests per the product prescribing information
> • Intravenous infusion of the medicine
> There is a $2,000 maximum benefit per calendar year for Treatment Administration Cost Support. The patient or healthcare 
> provider is required to submit an Explanation of Benefits (EOB) following each laboratory test or infusion to the TREMFYA withMe 
> Savings Program. Terms expire at the end of each calendar year. Offer subject to change or end without notice, including in specific 
> states. Not valid for residents of MA, MN, or RI.”

Source: [TREMFYA: TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf, page 2, captured 2026-11-13](https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf#page=2)

<a id="tremfya-savings-accumulators"></a>

### Does the Tremfya savings program work with accumulators, maximizers, or SaveOnSP?

> “Some health plans have programs or benefit designs known as “accumulators” or “maximizers.” These programs divert patient 
> assistance funds away from patients. 
> • Accumulators don’t allow patient assistance to count toward the patient’s deductible and out-of-pocket maximum until the 
> maximum value of the patient assistance is reached. 
> • Maximizers also don’t allow patient assistance to count toward the patient’s deductible and out-of-pocket maximum. 
> Maximizers apply the full value of the patient assistance over the year. This could be either the same amount each month or 
> a larger amount early in the year that tapers off, without allowing any of those funds to count toward the patient’s annual 
> deductible or out-of-pocket maximum. 
> • The TREMFYA withMe Savings Program is designed solely for the benefit of the patient. Thus, Johnson & Johnson reserves the 
> right to reduce the TREMFYA withMe Savings Program maximum benefit for patients in an accumulator or maximizer program or 
> benefit design, except where prohibited by law.”

Source: [TREMFYA: TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf, page 2, captured 2026-11-13](https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf#page=2)

> “The TREMFYA withMe Savings Program is designed solely for the benefit of the patient. If your insurance company or health 
> plan partners with SaveOnSP, then except where prohibited by law, you will not be eligible for, and you agree not to use, the 
> TREMFYA withMe Savings Program.”

Source: [TREMFYA: TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf, page 3, captured 2026-11-13](https://www.janssencarepath.com/sites/www.janssencarepath-v1.com/files/TREMFYA-withMe_Savings-Program-Web-Flashcard.pdf#page=3)

<a id="tremfya-patient-assistance"></a>

### Is there a Tremfya patient assistance program for uninsured patients?

> “Your patients may still be eligible for support
>
> Visit JNJwithMe.com/hcp/Tremfya to view options available for your patients.”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#for-no-insurance:~:text=Your%20patients%20may%20still%20be,options%20available%20for%20your%20patients.)

On the page, select: No insurance coverage

> “Patient assistance from Johnson & Johnson is available if your patient is uninsured or has commercial, employer-sponsored, or government coverage that does not fully meet their needs. Your patient may be eligible to receive their medicine from J&J at no cost for up to one year if they meet the eligibility and income requirements for the Johnson & Johnson Patient Assistance Program. See terms and conditions at PatientAssistanceInfo.com/IMM.”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#for-no-insurance:~:text=Patient%20assistance%20from%20Johnson%20%26,terms%20and%20conditions%20at%20PatientAssistanceInfo.com%2FIMM.)

On the page, select: No insurance coverage

<a id="tremfya-insurance-coverage"></a>

### Is Tremfya covered by commercial insurance and Medicare Part D?

> “TREMFYA<sup>®</sup> has nearly<sup>IIII</sup> 100% commercial coverage and preferred<sup>¶¶</sup> coverage for >90% Medicare Part D lives.”

Source: [TREMFYA: Moderate To Severe Plaque PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/#:~:text=100%25%20commercial%20coverage%20and,%3E90%25%20Medicare%20Part%20D%20lives.)

> “Source: Managed Markets Insight & Technology, LLC<sup>TM</sup>, a trademark of MMIT, as of April 2026. Collected as of 04/26 and may change. These percentages may not represent 100% of formulary lives due to data limitations.”

Source: [TREMFYA: Moderate To Severe Plaque PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/#:~:text=Source%3A%20Managed%20Markets%20Insight%20%26,lives%20due%20to%20data%20limitations.)

> ““Nearly” means absolute difference less than +/- 2% of the actual number. Within 2% of the access being stated.”

Source: [TREMFYA: Moderate To Severe Plaque PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/#:~:text=%E2%80%9CNearly%E2%80%9D%20means%20absolute%20difference%20less,of%20the%20access%20being%20stated.)

> ““Preferred” means TREMFYA<sup>®</sup> can be accessed first-line (ie, step therapy is not required) and its formulary status is better than or equivalent to other products in the class.”

Source: [TREMFYA: Moderate To Severe Plaque PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/#:~:text=%E2%80%9CPreferred%E2%80%9D%20means,other%20products%20in%20the%20class.)

Note: The coverage figures are the manufacturer's statements based on MMIT formulary data as of April 2026.

<a id="tremfya-medicare-part-d-plans"></a>

### Which Medicare Part D plans cover Tremfya as first-line preferred?

> “TREMFYA<sup>®</sup> Medicare Part D Coverage
> Plan Name
> Channel
> TREMFYA<sup>®</sup> Formulary Status
> CVS Aetna
> Medicare Part D
> 1L Preferred (began June 1, 2024)
> ESI/CIGNA and CENTENE
> Medicare Part D
> 1L Preferred (began January 1, 2025)
> Humana
> Medicare Part D
> 1L Preferred (began January 1, 2025)
> Major Regional Plans
> Medicare Part D
> 1L Preferred (began January 1, 2025)”

Source: [TREMFYA: covered plans, page 1, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Part_D_Win_Digital_Flashcard.pdf#page=1)

> “TREMFYA<sup>®</sup> has preferred* 1L Medicare Part D coverage 
> on CVS AETNA and has expanded<sup>†</sup> its coverage for 
> majority<sup>‡</sup> of Medicare Part D lives.”

Source: [TREMFYA: covered plans, page 1, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Part_D_Win_Digital_Flashcard.pdf#page=1)

> “Majority” means 51-65% number of covered lives.”

Source: [TREMFYA: covered plans, page 1, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Part_D_Win_Digital_Flashcard.pdf#page=1)

> ““Preferred” means TREMFYA<sup>®</sup> can be accessed first-line (ie, step therapy is not required) and its formulary status is better than or equivalent to 
> other products in the class.”

Source: [TREMFYA: covered plans, page 1, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Part_D_Win_Digital_Flashcard.pdf#page=1)

> “Source: Data on file, Janssen Biotech, Inc., as of September 2024 and may change. Managed Markets Insight & Technology, LLC™, a trademark 
> of MMIT, as of December 2024. Collected as of 12/24 and may change.”

Source: [TREMFYA: covered plans, page 1, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Part_D_Win_Digital_Flashcard.pdf#page=1)

Note: This flashcard is dated January 2025 and uses MMIT data collected in December 2024, when it defines its majority of Medicare Part D lives as 51% to 65%. The plaque psoriasis page reports preferred coverage for more than 90% of Medicare Part D lives based on MMIT data as of April 2026; plan-level status may have changed since the flashcard.

<a id="tremfya-medicare-payment-plan"></a>

### Can Medicare patients spread Tremfya costs over the year?

> “New Optional Payment Program: Patients can enroll in the 
> Medicare Prescription Payment Plan to spread out their 
> prescription costs over the year”

Source: [TREMFYA: covered plans, page 2, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Part_D_Win_Digital_Flashcard.pdf#page=2)

Note: The Medicare Prescription Payment Plan is a Medicare program for drugs a patient's Part D plan covers; this January 2025 Tremfya flashcard describes it.

## Prior authorization

<a id="tremfya-letter-of-medical-necessity"></a>

### Is there a Tremfya letter of medical necessity template?

> “Letter of Medical Necessity
> • Visit JNJwithMe.com/hcp/Tremfya and look under the 
> Forms and Documents drop-down for a sample letter
> • For expedited requests, adequate information should be 
> provided to support the urgent nature of the request”

Source: [TREMFYA: Tremfya_Prior_Authorization_Checklist.pdf, page 2, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Tremfya_Prior_Authorization_Checklist.pdf#page=2)

## Access support

<a id="tremfya-specialty-pharmacy"></a>

### Is Tremfya available through specialty pharmacies?

> “TREMFYA<sup>®</sup> (guselkumab) is widely available through open distribution at any specialty pharmacy of choice. Additionally, the specialty 
> pharmacies listed here are contracted to provide enhanced services to patients, such as further education and adherence support, and 
> transfers to payer-mandated pharmacies.”

Source: [TREMFYA: TREMFYA_SP_REFERENCE_LIST_DIGITAL.pdf, page 1, captured 2026-11-13](https://www.tremfya.com/files/TREMFYA_SP_REFERENCE_LIST_DIGITAL.pdf#page=1)

> “The above represents a partial list of specialty pharmacies supplying TREMFYA<sup>®</sup>. It is not intended to serve as a comprehensive list.”

Source: [TREMFYA: TREMFYA_SP_REFERENCE_LIST_DIGITAL.pdf, page 1, captured 2026-11-13](https://www.tremfya.com/files/TREMFYA_SP_REFERENCE_LIST_DIGITAL.pdf#page=1)

## Patient support

<a id="tremfya-withme-support"></a>

### What support does the Tremfya withMe program offer?

> “TREMFYA withMe offers free resources and dedicated support for patients who have been prescribed TREMFYA<sup>®</sup>.
> Supporting your patients at every step
>
> Nurse Guide* support
>
> Specialty Pharmacy Enhanced Services
>
> Access and affordability support
>
> Dedicated Case Manager team”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#:~:text=TREMFYA%20withMe%20offers%20free%20resources,Dedicated%20Case%20Manager%20team)

> “TREMFYA withMe can help verify insurance coverage for your 
> patients, provide reimbursement information, find financial assistance options for eligible patients, and provide ongoing support to help patients start 
> and stay on TREMFYA®.”

Source: [TREMFYA: Tremfya_Prior_Authorization_Checklist.pdf, page 2, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/files/Tremfya_Prior_Authorization_Checklist.pdf#page=2)

> “The patient support and resources provided by TREMFYA withMe are not intended to give medical advice, replace a treatment plan from the patient’s healthcare provider, offer services that would normally be performed by the provider’s office, or serve as a reason to prescribe TREMFYA<sup>®</sup>.”

Source: [TREMFYA: TREMFYA® withMe for PsO, captured 2026-11-13](https://www.tremfyahcp.com/plaque-psoriasis/access-and-support/tremfya-withme/#:~:text=The%20patient%20support%20and%20resources,as%20a%20reason%20to%20prescribe)

## Related pages
- [Medical information: Tremfya (guselkumab): All indications](https://www.evicenter.com/medical-information/tremfya)
- [Indication](https://www.evicenter.com/medical-information/tremfya/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/tremfya/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/tremfya/safety)
- [Specific populations](https://www.evicenter.com/medical-information/tremfya/specific-populations)
- [Drug interactions](https://www.evicenter.com/medical-information/tremfya/drug-interactions)
- [Dosing and administration](https://www.evicenter.com/medical-information/tremfya/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/tremfya/storage-and-supply)
